Govt expects speedy launch of single-dose Sputnik Light vaccine

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been......

Apollo Hospitals launches pilot for Sputnik V vaccine

Apollo Hospitals and Dr Reddy's Laboratories on Monday said they are collaborating to initiate a COVID-19 vaccination programme in the country with Sputnik V. IMAGE: Second batch of Sputnik-V......

Sputnik V vaccine to be available in India from next week: Govt

India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi. Photograph: Kind courtesy Russian Direct Investment Fund on Facebook Sputnik V, the......

Anti-Covid drug developed by DRDO cleared for emergency use

An anti-COVID oral drug developed by the Defence Research and Development Organisation has been approved by the Drugs Controller General of India for emergency use as an adjunct therapy in moderate......

Trade generics growth to dent value expansion of domestic drug market

Rising penetration of trade generic medicines is eating into the value growth of the domestic pharmaceutical market, showed a recent analysis. Photograph: Jacky Naegelen/Reuters According to a......

Cipla on the block: Who's a better fit and what it means for shareholders?

India’s third-largest pharmaceutical company by revenue, Cipla, is up for grabs in a three-way fight between Torrent Pharmaceuticals, Dr Reddy’s Laboratories (DRL) and private equity......

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market. Image used for......

US drug shortage, stable pricing set to boost pharma revenues

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India’s pharmaceutical companies during the first quarter of this financial......